Health Condition 1: C61- Malignant neoplasm of prostate
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients aged >= 18 years 2) Prostate cancer Any T, any N, M0 or M1
Exclusion criteria
Exclusion criteria: 1. Patients who are not willing to participate and will not provide signed informed consent 2. Patients with metabolic disorders 3. Thyrotoxicosis patients 4. Patients with uncontrolled DM, defined as HbA1c >=7.5% 5. Patients with hepatic dysfunction that is those in whom serum bilirubin will be more than 1.5 and, AST and ALT will be more than 2.5 fold higher than the upper limit of normal at baseline 6. Patients in whom serum creatinine will be more than 1.5 fold higher than the upper limit of normal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) To compare the differences in metabolites in blood samples of patients a) With bone metastasis (high grade) b) Without bone metastasis (low grade) (2) To identify differences in metabolites in blood samples of a) ADT responders or CSPC b) ADT non responders or CRPC Comparison will be made with healthy age matched male individuals (3) To create a metabolomics database for prostate cancer Timepoint: at Baseline: at the time of recruitment of the patient in the study in different groups | — |
Secondary
| Measure | Time frame |
|---|---|
| N/ATimepoint: N/A | — |
Countries
India
Contacts
All India Institute of Medical Sciences